Additionally, the expressions of the feature biomarkers were validated in clinical tissues, which demonstrated that patients with RA had a higher expression of AKR1C3, MCEE, and POLE4 and a lower expression of PFKM (Figures 6A–6D, 7A–7E). The gene discussed is POLE4; the disease is rheumatoid arthritis.